PIMA517635

Factor VII Monoclonal Antibody (AD-1), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIMA517635-Each-of-1 In Stock ₹ 47,036.50

PIMA517635 - Each of 1

₹ 47,036.50

In Stock

Quantity

1

Base Price: ₹ 47,036.50

GST (18%): ₹ 8,466.57

Total Price: ₹ 55,503.07

Antigen

Factor VII

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

P08709

Gene Symbols

F7

Immunogen

Human Factor VII (AD-1) purified from plasma.

Quantity

200 μg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Western Blot

Clone

AD-1

Conjugate

Unconjugated

Gene

F7

Gene Alias

AI132620; Cf7; Coagulation factor VII; coagulation factor VII (serum prothrombin conversion accelerator); eptacog alfa; F7; Factor 7; Factor VII heavy chain; Factor VII light chain; Factor7; FVII; FVII coagulation protein; proconvertin; Serum prothrombin conversion accelerator; SPCA

Host Species

Mouse

Purification Method

Protein G

Regulatory Status

RUO

Gene ID (Entrez)

2155

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Related Products

Img

Thermo Scientific

PIMA516932

--

Img

Thermo Scientific

PIMA517632

--

Img

Thermo Scientific

PIMA517629

--

Img

Thermo Scientific

PIMA143001

--

Img

Thermo Scientific

PIMA143003

--

Img

Thermo Scientific

PIMA143002

--

Img

Thermo Scientific

PIMA143009

--

Img

Thermo Scientific

PIMA143010

--

Description

  • MA5-17635 targets Factor VII/VIIa in ELISA and WB applications and shows reactivity with Human samples
  • The MA5-17635 immunogen is human Factor VII (AD-1) purified from plasma
  • Coagulation factor VII is a vitamin K-dependent factor essential for hemostasis
  • This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis
  • Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond
  • In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa
  • Defects in F7 production can cause coagulopathy.